
    
      In patients with pre-existing diabetic macular edema, anti-vascular endothelial growth factor
      therapy (Bevacizumab, ranibizumab, or aflibercept) will be compared to Ozurdex therapy
      administered 1 week prior to phacoemulsification cataract extraction. Spectral domain optical
      coherence tomography and visual acuity will be acquired at 1 week, 1 month, 2 months, and 3
      months following cataract surgery.
    
  